Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population
Antimicrob Steward Healthc Epidemiol
.
2021 Jun 24;1(1):e3.
doi: 10.1017/ash.2021.165.
eCollection 2021.
Authors
Scott A Borgetti
1
,
Alan E Gross
2
,
Janey Kottler
3
,
Kenil Patel
2
,
Jamie Paek
2
,
Alfredo J Mena Lora
1
,
Diane Oikle
4
,
Delisa Jeffries
4
,
Jon Radosta
1
Affiliations
1
Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
2
Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
3
College of Nursing, University of Illinois at Chicago, Chicago, Illinois.
4
Ambulatory Services Administration, University of Illinois at Chicago, Chicago, Illinois.
PMID:
36168464
PMCID:
PMC9495403
DOI:
10.1017/ash.2021.165
No abstract available